Smarter leaders trust GlobalData

Data Insights Covid-19 in pharma: synthetic COVID vaccines

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

Johnson & Johnson

Sanofi

GSK plc

SEEK Ltd

Valneva SE

View all

According to GlobalData’s Technology Foresights, which uses over 730,000 patents to analyze innovation intensity for the pharmaceutical industry, there are 80+ innovation areas that will shape the future of the industry.

Synthetic COVID vaccines is a key innovation area in Covid-19 therapy

Synthetic COVID vaccines refer to vaccines that are designed and produced using synthetic biology techniques, rather than traditional methods of vaccine production. A synthetic vaccine mainly consists of synthetic peptides, carbohydrates, or antigens for COVID. They are usually considered to be safer than vaccines from bacterial cultures. Creating vaccines synthetically can increase the speed of production.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 960+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of synthetic COVID vaccines.

Key players in synthetic COVID vaccines – a disruptive innovation in the pharmaceutical industry

 Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.   

‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.  

Patent volumes related to synthetic COVID vaccines

Johnson & Johnson (J&J) is one of the leading patent filers in synthetic COVID vaccines. J&J researches, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious such as Covid-19, cardiovascular, and metabolic diseases. Jcovden is an approved synthetic vaccine, which was developed by Johnson & Johnson. GSK and Sanofi are some of the other key patent filers in synthetic COVID vaccines.

In terms of application diversity, Revvity leads the pack, while Gilead Sciences and Bio-Rad Laboratories stood in the second and third positions, respectively.

By means of geographic reach, SEEK Group held the top position, followed by Autoimmune Technologies and TheVax Genetics Vaccine.

To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Pharmaceutical.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.